EIC Accelerator - 2 life sciences start-ups from Berlin among the 71 selected companies
Two Berlin start-ups were able to impress with their business model:
Noah Labs receives 11 million euros in funding, and wants to revolutionize heart failure detection using AI-based voice monitoring.
MyoPax, a spin-off from the Max Delbrück Centrum and Charité - Universitätsmedizin Berlin, is developing a generative gene therapy for muscular dystrophies, which affect over 20 million EU citizens and for which there are no adequate treatment options in most cases.
Further information:
- EIC Accelerator – 71 companies selected in the most competitive funding round so far - European Commission
- LinkedIn Noah Labs
- LinkedIn MyoPax
- Im Portrait | Gen- und Zelltherapie: Da tut sich was | Cluster Gesundheitswirtschaft Berlin-Brandenburg [German only]